Toggle navigation
Home
Search
Services
Blog
Contact
About
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C.
Ribogene, Inc., Hayward, CA, United States
Search 4 grants from Julia Watson
Search grants from Ribogene, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Novel Tools for Familial Risk Prediction
Design of antibody fragments specific for amyloidogenic aggregates
Role of CD44/HA Pathway in Regulation of Neural Stem Cell Fate
Cross-Linguistic Studies in Phasia
Reflex Response to High Frequency Ventilation
Recently added grants:
Enhancing Cardiopoietic Regeneration for Ischemic Cardiomyopathy
Sigmar1 in lipid metabolism
A raphe-hippocampus pathway for regulation of memory specificity during consolidation
Macrophage Ontogeny Shifts in Ischemic Heart Disease
Cardiomyocyte CaM kinase II as a driver of cardiac inflammation and remodeling
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA065331-02A1
Application #
2008636
Study Section
Special Emphasis Panel (ZRG3-SSS-Z (01))
Project Start
1996-09-30
Project End
1998-09-29
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Ribogene, Inc.
Department
Type
DUNS #
City
Hayward
State
CA
Country
United States
Zip Code
94545
Related projects
NIH 1997
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
NIH 1996
R44 CA
Screening Assay for Anticancer and Antiviral Drugs
Watson, Julia C. / Ribogene, Inc.
Comments
Be the first to comment on Julia Watson's grant